‹ See all categories

New Creative Relevant Search filters Recombinant Stock Photos and Images  (827) recombinant dna | recombinant bacteria | recombinant human Related searches: Narrow your search: Vectors | Black & white | Cut Outs Page 1 of 9 DNA binding protein. Molecular model of the recombinant protein S7dLZ bound to DNA (deoxyribonucleic acid) molecules. S7dLZ is made up of the DNA binding protein Sac7d and the transcriptional activator GCN4. DNA binding protein. Molecular model of the recombinant protein S7dLZ bound to DNA (deoxyribonucleic acid) molecules. S7dLZ is made up of the DNA binding protein Sac7d and the transcriptional activator GCN4.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-dna-binding-protein-molecular-model-of-the-recombinant-protein-s7dlz-73687951.html A 3D surface model of the recombinant human insulin quaternary structure chains A and B, white background A 3D surface model of the recombinant human insulin quaternary structure chains A and B, white backgroundhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/a-3d-surface-model-of-the-recombinant-human-insulin-quaternary-structure-chains-a-and-b-white-background-image367941874.html Chromosomal crossover. maternal & paternal Homologous chromosomes and Exchange genetic material in meiosis. Sister and Recombinant chromatids. Vector Chromosomal crossover. maternal & paternal Homologous chromosomes and Exchange genetic material in meiosis. Sister and Recombinant chromatids. Vectorhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/chromosomal-crossover-maternal-paternal-homologous-chromosomes-and-exchange-genetic-material-in-meiosis-sister-and-recombinant-chromatids-vector-image389671919.html Mission Bay headquarters and sign for FibroGen, a biotechnology company producing recombinant gelatins for medical devices and pharmaceuticals, San Francisco, California, 2016. Mission Bay headquarters and sign for FibroGen, a biotechnology company producing recombinant gelatins for medical devices and pharmaceuticals, San Francisco, California, 2016.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-mission-bay-headquarters-and-sign-for-fibrogen-a-biotechnology-company-170284289.html A 3D cartoon model of the recombinant human insulin quaternary structure chains A and B, white background A 3D cartoon model of the recombinant human insulin quaternary structure chains A and B, white backgroundhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/a-3d-cartoon-model-of-the-recombinant-human-insulin-quaternary-structure-chains-a-and-b-white-background-image367941877.html Horizontal gene transfer for example bacteria. Transfer of DNA via a plasmid from a donor to a recombinant recipient during cell-to-cell contact Horizontal gene transfer for example bacteria. Transfer of DNA via a plasmid from a donor to a recombinant recipient during cell-to-cell contacthttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/horizontal-gene-transfer-for-example-bacteria-transfer-of-dna-via-a-plasmid-from-a-donor-to-a-recombinant-recipient-during-cell-to-cell-contact-image389237228.html CESG Protein Purification Facility CESG Protein Purification Facilityhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/cesg-protein-purification-facility-image352788655.html Hepatitis B vaccine recombinant Hepatitis B vaccine recombinanthttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/hepatitis-b-vaccine-recombinant-image206871136.html Sol Spiegelman (1914-1983) was an American molecular biologist whose pioneering discoveries accelerated the study of gene mechanisms and laid the foundations of recombinant DNA technology. Sol Spiegelman working in University of Illinois lab 1974 Sol Spiegelman (1914-1983) was an American molecular biologist whose pioneering discoveries accelerated the study of gene mechanisms and laid the foundations of recombinant DNA technology. Sol Spiegelman working in University of Illinois lab 1974https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-sol-spiegelman-1914-1983-was-an-american-molecular-biologist-whose-84972090.html Artificial insemination using the ICSI method, intracytoplasmic sperm injection, under the microscope Artificial insemination using the ICSI method, intracytoplasmic sperm injection, under the microscopehttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/artificial-insemination-using-the-icsi-method-intracytoplasmic-sperm-injection-under-the-microscope-image232384910.html Hepatitis B vaccine recombinant Hepatitis B vaccine recombinanthttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/hepatitis-b-vaccine-recombinant-image206871138.html Sol Spiegelman (1914-1983) was an American molecular biologist whose pioneering discoveries accelerated the study of gene mechanisms and laid the foundations of recombinant DNA technology. Sol Spiegelman working in University of Illinois lab 1951 Sol Spiegelman (1914-1983) was an American molecular biologist whose pioneering discoveries accelerated the study of gene mechanisms and laid the foundations of recombinant DNA technology. Sol Spiegelman working in University of Illinois lab 1951https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-sol-spiegelman-1914-1983-was-an-american-molecular-biologist-whose-84972089.html Biotechnology laboratory, laminar flow, a scientist is pipetting a cell culture medium into a petri dish, Centre for Medical Biotechnology laboratory, laminar flow, a scientist is pipetting a cell culture medium into a petri dish, Centre for Medicalhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/biotechnology-laboratory-laminar-flow-a-scientist-is-pipetting-a-cell-culture-medium-into-a-petri-dish-centre-for-medical-image232210818.html Tertiary structure of human vitamin D receptor with the differently colored secondary structure elements, 3D cartoon model, white background Tertiary structure of human vitamin D receptor with the differently colored secondary structure elements, 3D cartoon model, white backgroundhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/tertiary-structure-of-human-vitamin-d-receptor-with-the-differently-colored-secondary-structure-elements-3d-cartoon-model-white-background-image382675660.html Chemist in a laboratory Chemist in a laboratoryhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-chemist-in-a-laboratory-26535373.html Forensic Pathology Research Forensic Pathology Researchhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-forensic-pathology-research-22875285.html Test tubes with samples in the research & development laboratory of a biochemical company doing recombinant dna research Test tubes with samples in the research & development laboratory of a biochemical company doing recombinant dna researchhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-test-tubes-with-samples-in-the-research-development-laboratory-of-41315808.html Chemist in a laboratory Chemist in a laboratoryhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-chemist-in-a-laboratory-26535297.html Vaxart Inc is a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Concept photo. Vaxart Inc is a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Concept photo.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/vaxart-inc-is-a-clinical-stage-biotechnology-company-which-engages-in-the-development-of-oral-recombinant-vaccines-concept-photo-image343275491.html Recombinant human follicle-stimulating hormone with shown carbohydrate molecules attached, 3D-model of the heterodimer quaternary structure Recombinant human follicle-stimulating hormone with shown carbohydrate molecules attached, 3D-model of the heterodimer quaternary structurehttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/recombinant-human-follicle-stimulating-hormone-with-shown-carbohydrate-molecules-attached-3d-model-of-the-heterodimer-quaternary-structure-image367941859.html Scientific background. Scientist checks sizes of recominant proteins on Western Blot. Shallow DOF, focus on the gel Scientific background. Scientist checks sizes of recominant proteins on Western Blot. Shallow DOF, focus on the gelhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-scientific-background-scientist-checks-sizes-of-recominant-proteins-171559438.html Artificial insemination, Centre for Reproductive Medicine, Centre for Fertility Treatment, private clinic in Duesseldorf Artificial insemination, Centre for Reproductive Medicine, Centre for Fertility Treatment, private clinic in Duesseldorfhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/artificial-insemination-centre-for-reproductive-medicine-centre-for-fertility-treatment-private-clinic-in-duesseldorf-image232384874.html Recombinant human follicle-stimulating hormone with shown carbohydrate molecules attached, 3D-model of the heterodimer quaternary structure Recombinant human follicle-stimulating hormone with shown carbohydrate molecules attached, 3D-model of the heterodimer quaternary structurehttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/recombinant-human-follicle-stimulating-hormone-with-shown-carbohydrate-molecules-attached-3d-model-of-the-heterodimer-quaternary-structure-image367941856.html St Petersburg, Russia. 16th Nov, 2018. ST PETERSBURG, RUSSIA - NOVEMBER 16, 2018: The President of Russia Vladimir Putin (C), and Geropharm General Director Pyotr (Petr) Rodionov (R) at Geropharm-Bio Plant owned by Geropharm Group; the production facility manufactures recombinant human insulin. Mikhail Klimentyev/Russian Presidential Press and Information Office/TASS Credit: ITAR-TASS News Agency/Alamy Live News St Petersburg, Russia. 16th Nov, 2018. ST PETERSBURG, RUSSIA - NOVEMBER 16, 2018: The President of Russia Vladimir Putin (C), and Geropharm General Director Pyotr (Petr) Rodionov (R) at Geropharm-Bio Plant owned by Geropharm Group; the production facility manufactures recombinant human insulin. Mikhail Klimentyev/Russian Presidential Press and Information Office/TASS Credit: ITAR-TASS News Agency/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-16th-nov-2018-st-petersburg-russia-november-16-2018-the-president-of-russia-vladimir-putin-c-and-geropharm-general-director-pyotr-petr-rodionov-r-at-geropharm-bio-plant-owned-by-geropharm-group-the-production-facility-manufactures-recombinant-human-insulin-mikhail-klimentyevrussian-presidential-press-and-information-officetass-credit-itar-tass-news-agencyalamy-live-news-image225074287.html Artificial insemination, Centre for Reproductive Medicine, Centre for Fertility Treatment, private clinic in Duesseldorf Artificial insemination, Centre for Reproductive Medicine, Centre for Fertility Treatment, private clinic in Duesseldorfhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/artificial-insemination-centre-for-reproductive-medicine-centre-for-fertility-treatment-private-clinic-in-duesseldorf-image232384872.html Lead Protein Production and Centrifugation scientist Paul Koelle operates a centrifuge control panel where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar Lead Protein Production and Centrifugation scientist Paul Koelle operates a centrifuge control panel where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segarhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/lead-protein-production-and-centrifugation-scientist-paul-koelle-operates-a-centrifuge-control-panel-where-they-are-working-on-developing-a-vaccine-for-the-zika-virus-based-on-production-of-recombinant-variations-of-the-e-protein-from-the-zika-virus-at-the-protein-sciences-inc-headquarters-in-meriden-connecticut-june-20-2016-picture-taken-june-20-2016-reutersmike-segar-image372706127.html St Petersburg, Russia. 16th Nov, 2018. ST PETERSBURG, RUSSIA - NOVEMBER 16, 2018: The President of Russia Vladimir Putin (2nd L front), and Geropharm General Director Pyotr (Petr) Rodionov (R) at Geropharm-Bio Plant owned by Geropharm Group; the production facility manufactures recombinant human insulin. Mikhail Klimentyev/Russian Presidential Press and Information Office/TASS Credit: ITAR-TASS News Agency/Alamy Live News St Petersburg, Russia. 16th Nov, 2018. ST PETERSBURG, RUSSIA - NOVEMBER 16, 2018: The President of Russia Vladimir Putin (2nd L front), and Geropharm General Director Pyotr (Petr) Rodionov (R) at Geropharm-Bio Plant owned by Geropharm Group; the production facility manufactures recombinant human insulin. Mikhail Klimentyev/Russian Presidential Press and Information Office/TASS Credit: ITAR-TASS News Agency/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-16th-nov-2018-st-petersburg-russia-november-16-2018-the-president-of-russia-vladimir-putin-2nd-l-front-and-geropharm-general-director-pyotr-petr-rodionov-r-at-geropharm-bio-plant-owned-by-geropharm-group-the-production-facility-manufactures-recombinant-human-insulin-mikhail-klimentyevrussian-presidential-press-and-information-officetass-credit-itar-tass-news-agencyalamy-live-news-image225074288.html Artificial insemination using the ICSI method, intracytoplasmic sperm injection, under the microscope Artificial insemination using the ICSI method, intracytoplasmic sperm injection, under the microscopehttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/artificial-insemination-using-the-icsi-method-intracytoplasmic-sperm-injection-under-the-microscope-image232384912.html Research scientist Dan Galperin works on Purified Recombinant Zika Enveloped Protein at his laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar Research scientist Dan Galperin works on Purified Recombinant Zika Enveloped Protein at his laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segarhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/research-scientist-dan-galperin-works-on-purified-recombinant-zika-enveloped-protein-at-his-laboratory-where-they-are-working-on-developing-a-vaccine-for-the-zika-virus-based-on-production-of-recombinant-variations-of-the-e-protein-from-the-zika-virus-at-the-protein-sciences-inc-headquarters-in-meriden-connecticut-us-june-20-2016-picture-taken-june-20-2016-reutersmike-segar-image375531505.html St Petersburg, Russia. 16th Nov, 2018. ST PETERSBURG, RUSSIA - NOVEMBER 16, 2018: The President of Russia Vladimir Putin (L front), Minister of Healthcare Veronika Skvortsova (L back), and St Petersburg's acting Governor Alexander Beglov (C back) visit Geropharm-Bio Plant owned by Geropharm Group; the production facility manufactures recombinant human insulin. Mikhail Klimentyev/Russian Presidential Press and Information Office/TASS Credit: ITAR-TASS News Agency/Alamy Live News St Petersburg, Russia. 16th Nov, 2018. ST PETERSBURG, RUSSIA - NOVEMBER 16, 2018: The President of Russia Vladimir Putin (L front), Minister of Healthcare Veronika Skvortsova (L back), and St Petersburg's acting Governor Alexander Beglov (C back) visit Geropharm-Bio Plant owned by Geropharm Group; the production facility manufactures recombinant human insulin. Mikhail Klimentyev/Russian Presidential Press and Information Office/TASS Credit: ITAR-TASS News Agency/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-16th-nov-2018-st-petersburg-russia-november-16-2018-the-president-of-russia-vladimir-putin-l-front-minister-of-healthcare-veronika-skvortsova-l-back-and-st-petersburgs-acting-governor-alexander-beglov-c-back-visit-geropharm-bio-plant-owned-by-geropharm-group-the-production-facility-manufactures-recombinant-human-insulin-mikhail-klimentyevrussian-presidential-press-and-information-officetass-credit-itar-tass-news-agencyalamy-live-news-image225074258.html Artificial insemination, Centre for Reproductive Medicine, Centre for Fertility Treatment, private clinic in Duesseldorf Artificial insemination, Centre for Reproductive Medicine, Centre for Fertility Treatment, private clinic in Duesseldorfhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/artificial-insemination-centre-for-reproductive-medicine-centre-for-fertility-treatment-private-clinic-in-duesseldorf-image232384871.html Lead Protein Production and Centrifugation scientist Paul Koelle operates a centrifuge control panel where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar Lead Protein Production and Centrifugation scientist Paul Koelle operates a centrifuge control panel where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segarhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/lead-protein-production-and-centrifugation-scientist-paul-koelle-operates-a-centrifuge-control-panel-where-they-are-working-on-developing-a-vaccine-for-the-zika-virus-based-on-production-of-recombinant-variations-of-the-e-protein-from-the-zika-virus-at-the-protein-sciences-inc-headquarters-in-meriden-connecticut-us-june-20-2016-picture-taken-june-20-2016-reutersmike-segar-image374053162.html St Petersburg, Russia. 16th Nov, 2018. ST PETERSBURG, RUSSIA - NOVEMBER 16, 2018: The President of Russia Vladimir Putin (L), Gerofarm General Director Pyotr (Petr) Rodionov (2nd L), and Russia's Minister of Industry and Trade Denis Manturov (C back) at Geropharm-Bio Plant owned by Geropharm Group; the production facility manufactures recombinant human insulin. Mikhail Klimentyev/Russian Presidential Press and Information Office/TASS Credit: ITAR-TASS News Agency/Alamy Live News St Petersburg, Russia. 16th Nov, 2018. ST PETERSBURG, RUSSIA - NOVEMBER 16, 2018: The President of Russia Vladimir Putin (L), Gerofarm General Director Pyotr (Petr) Rodionov (2nd L), and Russia's Minister of Industry and Trade Denis Manturov (C back) at Geropharm-Bio Plant owned by Geropharm Group; the production facility manufactures recombinant human insulin. Mikhail Klimentyev/Russian Presidential Press and Information Office/TASS Credit: ITAR-TASS News Agency/Alamy Live Newshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/st-petersburg-russia-16th-nov-2018-st-petersburg-russia-november-16-2018-the-president-of-russia-vladimir-putin-l-gerofarm-general-director-pyotr-petr-rodionov-2nd-l-and-russias-minister-of-industry-and-trade-denis-manturov-c-back-at-geropharm-bio-plant-owned-by-geropharm-group-the-production-facility-manufactures-recombinant-human-insulin-mikhail-klimentyevrussian-presidential-press-and-information-officetass-credit-itar-tass-news-agencyalamy-live-news-image225073970.html Artificial insemination using the ICSI method, intracytoplasmic sperm injection, under the microscope Artificial insemination using the ICSI method, intracytoplasmic sperm injection, under the microscopehttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/artificial-insemination-using-the-icsi-method-intracytoplasmic-sperm-injection-under-the-microscope-image232384891.html Lead Protein Production and Centrifugation scientist Paul Koelle looks into a large bio reactor where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar Lead Protein Production and Centrifugation scientist Paul Koelle looks into a large bio reactor where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segarhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/lead-protein-production-and-centrifugation-scientist-paul-koelle-looks-into-a-large-bio-reactor-where-they-are-working-on-developing-a-vaccine-for-the-zika-virus-based-on-production-of-recombinant-variations-of-the-e-protein-from-the-zika-virus-at-the-protein-sciences-inc-headquarters-in-meriden-connecticut-us-june-20-2016-picture-taken-june-20-2016-reutersmike-segar-image374643638.html Biofuel Research, Recombinant Streptomyces Biofuel Research, Recombinant Streptomyceshttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-biofuel-research-recombinant-streptomyces-135018758.html Artificial insemination using the ICSI method, intracytoplasmic sperm injection, under the microscope Artificial insemination using the ICSI method, intracytoplasmic sperm injection, under the microscopehttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/artificial-insemination-using-the-icsi-method-intracytoplasmic-sperm-injection-under-the-microscope-image232384884.html Manufacturing Associates Theodore Szmurlo and David Artus work in the cell culture room where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar Manufacturing Associates Theodore Szmurlo and David Artus work in the cell culture room where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segarhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/manufacturing-associates-theodore-szmurlo-and-david-artus-work-in-the-cell-culture-room-where-they-are-working-on-developing-a-vaccine-for-the-zika-virus-based-on-production-of-recombinant-variations-of-the-e-protein-from-the-zika-virus-at-the-protein-sciences-inc-headquarters-in-meriden-connecticut-us-june-20-2016-picture-taken-june-20-2016-reutersmike-segar-image374347480.html Kriminaltechnisches Institut, KTI, Forensic Science Institute, DNA analysis, trace carriers are examined for DNA evidence Kriminaltechnisches Institut, KTI, Forensic Science Institute, DNA analysis, trace carriers are examined for DNA evidencehttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/kriminaltechnisches-institut-kti-forensic-science-institute-dna-analysis-trace-carriers-are-examined-for-dna-evidence-image230263240.html March 24, 2020, Waltham, Massachusetts, USA: Sanofi in Waltham, Massachusetts: Sanofi facility in Waltham. Sanofi, multinational pharmaceutical company announce their partner with the U.S. Biomedical Advanced Research and Development Authority to make a coronavirus vaccine using the company recombinant DNA platform. March 24, 2020, Waltham, Massachusetts, USA: Sanofi in Waltham, Massachusetts: Sanofi facility in Waltham. Sanofi, multinational pharmaceutical company announce their partner with the U.S. Biomedical Advanced Research and Development Authority to make a coronavirus vaccine using the company recombinant DNA platform.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/march-24-2020-waltham-massachusetts-usa-sanofi-in-waltham-massachusetts-sanofi-facility-in-waltham-sanofi-multinational-pharmaceutical-company-announce-their-partner-with-the-us-biomedical-advanced-research-and-development-authority-to-make-a-coronavirus-vaccine-using-the-company-recombinant-dna-platform-image350744900.html Manufacturing Associates Theodore Szmurlo (L) and David Artus work in a cell culture room where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar Manufacturing Associates Theodore Szmurlo (L) and David Artus work in a cell culture room where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segarhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/manufacturing-associates-theodore-szmurlo-l-and-david-artus-work-in-a-cell-culture-room-where-they-are-working-on-developing-a-vaccine-for-the-zika-virus-based-on-production-of-recombinant-variations-of-the-e-protein-from-the-zika-virus-at-the-protein-sciences-inc-headquarters-in-meriden-connecticut-us-june-20-2016-picture-taken-june-20-2016-reutersmike-segar-image374756103.html Kriminaltechnisches Institut, KTI, Forensic Science Institute, DNA analysis, DNA screening, trace carriers are examined for DNA Kriminaltechnisches Institut, KTI, Forensic Science Institute, DNA analysis, DNA screening, trace carriers are examined for DNAhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/kriminaltechnisches-institut-kti-forensic-science-institute-dna-analysis-dna-screening-trace-carriers-are-examined-for-dna-image230263251.html March 24, 2020, Waltham, Massachusetts, USA: Sanofi in Waltham, Massachusetts: Sanofi facility in Waltham. Sanofi, multinational pharmaceutical company announce their partner with the U.S. Biomedical Advanced Research and Development Authority to make a coronavirus vaccine using the company recombinant DNA platform. March 24, 2020, Waltham, Massachusetts, USA: Sanofi in Waltham, Massachusetts: Sanofi facility in Waltham. Sanofi, multinational pharmaceutical company announce their partner with the U.S. Biomedical Advanced Research and Development Authority to make a coronavirus vaccine using the company recombinant DNA platform.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/march-24-2020-waltham-massachusetts-usa-sanofi-in-waltham-massachusetts-sanofi-facility-in-waltham-sanofi-multinational-pharmaceutical-company-announce-their-partner-with-the-us-biomedical-advanced-research-and-development-authority-to-make-a-coronavirus-vaccine-using-the-company-recombinant-dna-platform-image350744899.html Research scientist Dan Galperin works on Purified Recombinant Zika Enveloped Protein in his laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar Research scientist Dan Galperin works on Purified Recombinant Zika Enveloped Protein in his laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segarhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/research-scientist-dan-galperin-works-on-purified-recombinant-zika-enveloped-protein-in-his-laboratory-where-they-are-working-on-developing-a-vaccine-for-the-zika-virus-based-on-production-of-recombinant-variations-of-the-e-protein-from-the-zika-virus-at-the-protein-sciences-inc-headquarters-in-meriden-connecticut-us-june-20-2016-picture-taken-june-20-2016-reutersmike-segar-image373064636.html Kriminaltechnisches Institut, KTI, Forensic Science Institute, DNA analysis, DNA screening, trace carriers are examined for DNA Kriminaltechnisches Institut, KTI, Forensic Science Institute, DNA analysis, DNA screening, trace carriers are examined for DNAhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/kriminaltechnisches-institut-kti-forensic-science-institute-dna-analysis-dna-screening-trace-carriers-are-examined-for-dna-image230263249.html Genetically modified organisms are produced using scientific methods that include recombinant DNA technology. Genetically modified organisms are produced using scientific methods that include recombinant DNA technology.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-genetically-modified-organisms-are-produced-using-scientific-methods-24373118.html Research scientist Dan Galperin works on Purified Recombinant Zika Enveloped Protein in his laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar Research scientist Dan Galperin works on Purified Recombinant Zika Enveloped Protein in his laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segarhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/research-scientist-dan-galperin-works-on-purified-recombinant-zika-enveloped-protein-in-his-laboratory-where-they-are-working-on-developing-a-vaccine-for-the-zika-virus-based-on-production-of-recombinant-variations-of-the-e-protein-from-the-zika-virus-at-the-protein-sciences-inc-headquarters-in-meriden-connecticut-us-june-20-2016-picture-taken-june-20-2016-reutersmike-segar-image373889901.html Kriminaltechnisches Institut, KTI, Forensic Science Institute, DNA analysis, DNA screening, trace carriers are examined for DNA Kriminaltechnisches Institut, KTI, Forensic Science Institute, DNA analysis, DNA screening, trace carriers are examined for DNAhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/kriminaltechnisches-institut-kti-forensic-science-institute-dna-analysis-dna-screening-trace-carriers-are-examined-for-dna-image230263252.html Recombinant DNA technology can be used to breed knockout (homozygous) offspring for studying the effects of gene inactivation. Recombinant DNA technology can be used to breed knockout (homozygous) offspring for studying the effects of gene inactivation.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-recombinant-dna-technology-can-be-used-to-breed-knockout-homozygous-24373113.html Research scientist Dan Galperin works on Purified Recombinant Zika Enveloped Protein in his laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar Research scientist Dan Galperin works on Purified Recombinant Zika Enveloped Protein in his laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segarhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/research-scientist-dan-galperin-works-on-purified-recombinant-zika-enveloped-protein-in-his-laboratory-where-they-are-working-on-developing-a-vaccine-for-the-zika-virus-based-on-production-of-recombinant-variations-of-the-e-protein-from-the-zika-virus-at-the-protein-sciences-inc-headquarters-in-meriden-connecticut-us-june-20-2016-picture-taken-june-20-2016-reutersmike-segar-image373796930.html Kriminaltechnisches Institut, KTI, Forensic Science Institute, DNA analysis, DNA screening, trace carriers are examined for DNA Kriminaltechnisches Institut, KTI, Forensic Science Institute, DNA analysis, DNA screening, trace carriers are examined for DNAhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/kriminaltechnisches-institut-kti-forensic-science-institute-dna-analysis-dna-screening-trace-carriers-are-examined-for-dna-image230263253.html Interferon gamma (IFNg) cytokine molecule, chemical structure. Recombinant form used in treatment of osteopetrosis and chronic granulomatous disease. Ball-and-stick model. Coloured per chain. Interferon gamma (IFNg) cytokine molecule, chemical structure. Recombinant form used in treatment of osteopetrosis and chronic granulomatous disease. Ball-and-stick model. Coloured per chain.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/interferon-gamma-ifng-cytokine-molecule-chemical-structure-recombinant-image150557150.html Manufacturing Associate Theodore Szmurlo views a cell sample with a microscope as he works in the cell culture room where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar Manufacturing Associate Theodore Szmurlo views a cell sample with a microscope as he works in the cell culture room where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segarhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/manufacturing-associate-theodore-szmurlo-views-a-cell-sample-with-a-microscope-as-he-works-in-the-cell-culture-room-where-they-are-working-on-developing-a-vaccine-for-the-zika-virus-based-on-production-of-recombinant-variations-of-the-e-protein-from-the-zika-virus-at-the-protein-sciences-inc-headquarters-in-meriden-connecticut-us-june-20-2016-picture-taken-june-20-2016-reutersmike-segar-image375763672.html Kriminaltechnisches Institut, KTI, Forensic Science Institute, examination of evidence for possible DNA traces with UV light Kriminaltechnisches Institut, KTI, Forensic Science Institute, examination of evidence for possible DNA traces with UV lighthttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/kriminaltechnisches-institut-kti-forensic-science-institute-examination-of-evidence-for-possible-dna-traces-with-uv-light-image230263257.html Interferon gamma (IFNg) cytokine molecule, chemical structure. Recombinant form used in treatment of osteopetrosis and chronic granulomatous disease. Space-filling model with conventional colour coding. Interferon gamma (IFNg) cytokine molecule, chemical structure. Recombinant form used in treatment of osteopetrosis and chronic granulomatous disease. Space-filling model with conventional colour coding.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/interferon-gamma-ifng-cytokine-molecule-chemical-structure-recombinant-image150557157.html Research scientist Dan Galperin points to a screen displaying an isolated Purified Recombinant Zika Enveloped Protein in his laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar Research scientist Dan Galperin points to a screen displaying an isolated Purified Recombinant Zika Enveloped Protein in his laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segarhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/research-scientist-dan-galperin-points-to-a-screen-displaying-an-isolated-purified-recombinant-zika-enveloped-protein-in-his-laboratory-where-they-are-working-on-developing-a-vaccine-for-the-zika-virus-based-on-production-of-recombinant-variations-of-the-e-protein-from-the-zika-virus-at-the-protein-sciences-inc-headquarters-in-meriden-connecticut-us-june-20-2016-picture-taken-june-20-2016-reutersmike-segar-image372532983.html Kriminaltechnisches Institut, KTI, Forensic Science Institute, examination of evidence for possible DNA traces with UV light Kriminaltechnisches Institut, KTI, Forensic Science Institute, examination of evidence for possible DNA traces with UV lighthttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/kriminaltechnisches-institut-kti-forensic-science-institute-examination-of-evidence-for-possible-dna-traces-with-uv-light-image230263255.html Interferon gamma (IFNg) cytokine molecule, chemical structure. Recombinant form used in treatment of osteopetrosis and chronic granulomatous disease. Cartoon model, secondary structure colouring (helices blue). Interferon gamma (IFNg) cytokine molecule, chemical structure. Recombinant form used in treatment of osteopetrosis and chronic granulomatous disease. Cartoon model, secondary structure colouring (helices blue).https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/interferon-gamma-ifng-cytokine-molecule-chemical-structure-recombinant-image150557156.html Manufacturing Associate Theodore Szmurlo transfers a cell sample to a microscope slide as he works in the cell culture room where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar Manufacturing Associate Theodore Szmurlo transfers a cell sample to a microscope slide as he works in the cell culture room where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segarhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/manufacturing-associate-theodore-szmurlo-transfers-a-cell-sample-to-a-microscope-slide-as-he-works-in-the-cell-culture-room-where-they-are-working-on-developing-a-vaccine-for-the-zika-virus-based-on-production-of-recombinant-variations-of-the-e-protein-from-the-zika-virus-at-the-protein-sciences-inc-headquarters-in-meriden-connecticut-us-june-20-2016-picture-taken-june-20-2016-reutersmike-segar-image375931223.html Kriminaltechnisches Institut, KTI, Forensic Science Institute, examination of evidence for possible DNA traces with UV light Kriminaltechnisches Institut, KTI, Forensic Science Institute, examination of evidence for possible DNA traces with UV lighthttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/kriminaltechnisches-institut-kti-forensic-science-institute-examination-of-evidence-for-possible-dna-traces-with-uv-light-image230263256.html Interferon gamma (IFNg) cytokine molecule, chemical structure. Recombinant form used in treatment of osteopetrosis and chronic granulomatous disease. Cartoon model, secondary structure colouring (helices blue). Interferon gamma (IFNg) cytokine molecule, chemical structure. Recombinant form used in treatment of osteopetrosis and chronic granulomatous disease. Cartoon model, secondary structure colouring (helices blue).https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/interferon-gamma-ifng-cytokine-molecule-chemical-structure-recombinant-image150557155.html Manufacturing Associate Theodore David Artus works in a cell culture room where scientists are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. To match Analysis HEALTH-ZIKA/VACCINES REUTERS/Mike Segar Manufacturing Associate Theodore David Artus works in a cell culture room where scientists are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. To match Analysis HEALTH-ZIKA/VACCINES REUTERS/Mike Segarhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/manufacturing-associate-theodore-david-artus-works-in-a-cell-culture-room-where-scientists-are-working-on-developing-a-vaccine-for-the-zika-virus-based-on-production-of-recombinant-variations-of-the-e-protein-from-the-zika-virus-at-the-protein-sciences-inc-headquarters-in-meriden-connecticut-us-june-20-2016-picture-taken-june-20-2016-to-match-analysis-health-zikavaccines-reutersmike-segar-image373160606.html Kriminaltechnisches Institut, KTI, Forensic Science Institute, DNA analysis, trace carriers are examined for DNA evidence Kriminaltechnisches Institut, KTI, Forensic Science Institute, DNA analysis, trace carriers are examined for DNA evidencehttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/kriminaltechnisches-institut-kti-forensic-science-institute-dna-analysis-trace-carriers-are-examined-for-dna-evidence-image230263247.html Interferon gamma (IFNg) cytokine molecule, chemical structure. Recombinant form used in treatment of osteopetrosis and chronic granulomatous disease. Space-filling model. Chains shown in different colours. Interferon gamma (IFNg) cytokine molecule, chemical structure. Recombinant form used in treatment of osteopetrosis and chronic granulomatous disease. Space-filling model. Chains shown in different colours.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/interferon-gamma-ifng-cytokine-molecule-chemical-structure-recombinant-image150557154.html Protein Sciences Inc. President and CEO Manon Cox speaks during an interview with Reuters at a Protein Sciences Inc. research laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar Protein Sciences Inc. President and CEO Manon Cox speaks during an interview with Reuters at a Protein Sciences Inc. research laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segarhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/protein-sciences-inc-president-and-ceo-manon-cox-speaks-during-an-interview-with-reuters-at-a-protein-sciences-inc-research-laboratory-where-they-are-working-on-developing-a-vaccine-for-the-zika-virus-based-on-production-of-recombinant-variations-of-the-e-protein-from-the-zika-virus-at-the-protein-sciences-inc-headquarters-in-meriden-connecticut-us-june-20-2016-picture-taken-june-20-2016-reutersmike-segar-image375472656.html Kriminaltechnisches Institut, KTI, Forensic Science Institute, DNA analysis, trace carriers are examined for DNA evidence Kriminaltechnisches Institut, KTI, Forensic Science Institute, DNA analysis, trace carriers are examined for DNA evidencehttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/kriminaltechnisches-institut-kti-forensic-science-institute-dna-analysis-trace-carriers-are-examined-for-dna-evidence-image230263242.html Interferon gamma (IFNg) cytokine molecule, chemical structure. Recombinant form used in treatment of osteopetrosis and chronic granulomatous disease. Space-filling model. Chains shown in different colours. Interferon gamma (IFNg) cytokine molecule, chemical structure. Recombinant form used in treatment of osteopetrosis and chronic granulomatous disease. Space-filling model. Chains shown in different colours.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/interferon-gamma-ifng-cytokine-molecule-chemical-structure-recombinant-image150557153.html Research scientist Dan Galperin holds vials marked 'Zika' during his work on Purified Recombinant Zika Enveloped Protein at the research laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar Research scientist Dan Galperin holds vials marked 'Zika' during his work on Purified Recombinant Zika Enveloped Protein at the research laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segarhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/research-scientist-dan-galperin-holds-vials-marked-zika-during-his-work-on-purified-recombinant-zika-enveloped-protein-at-the-research-laboratory-where-they-are-working-on-developing-a-vaccine-for-the-zika-virus-based-on-production-of-recombinant-variations-of-the-e-protein-from-the-zika-virus-at-the-protein-sciences-inc-headquarters-in-meriden-connecticut-us-june-20-2016-picture-taken-june-20-2016-reutersmike-segar-image373149318.html Kriminaltechnisches Institut, KTI, Forensic Science Institute, DNA analysis, trace carriers are examined for DNA evidence Kriminaltechnisches Institut, KTI, Forensic Science Institute, DNA analysis, trace carriers are examined for DNA evidencehttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/kriminaltechnisches-institut-kti-forensic-science-institute-dna-analysis-trace-carriers-are-examined-for-dna-evidence-image230263246.html Interferon gamma (IFNg) cytokine molecule, chemical structure. Recombinant form used in treatment of osteopetrosis and chronic granulomatous disease. Space-filling model. Chains shown in different colours. Interferon gamma (IFNg) cytokine molecule, chemical structure. Recombinant form used in treatment of osteopetrosis and chronic granulomatous disease. Space-filling model. Chains shown in different colours.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/interferon-gamma-ifng-cytokine-molecule-chemical-structure-recombinant-image150557151.html The steps involved in the engineering of a recombinant DNA molecule. The steps involved in the engineering of a recombinant DNA molecule.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-the-steps-involved-in-the-engineering-of-a-recombinant-dna-molecule-24898985.html Kriminaltechnisches Institut, KTI, Forensic Science Institute, DNA analysis, trace carriers are examined for DNA evidence Kriminaltechnisches Institut, KTI, Forensic Science Institute, DNA analysis, trace carriers are examined for DNA evidencehttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/kriminaltechnisches-institut-kti-forensic-science-institute-dna-analysis-trace-carriers-are-examined-for-dna-evidence-image230263239.html Interferon gamma (IFNg) cytokine molecule, chemical structure. Recombinant form used in treatment of osteopetrosis and chronic granulomatous disease. Combined wireframe and cartoon model. Cartoon and carbon atoms: backbone gradient colouring (blue-teal); other atoms: conventional colour coding. Interferon gamma (IFNg) cytokine molecule, chemical structure. Recombinant form used in treatment of osteopetrosis and chronic granulomatous disease. Combined wireframe and cartoon model. Cartoon and carbon atoms: backbone gradient colouring (blue-teal); other atoms: conventional colour coding.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/interferon-gamma-ifng-cytokine-molecule-chemical-structure-recombinant-image150557159.html Laboratory, pipetting of DNA samples into Eppendorf tubes, Centre for Medical Biotechnology University Duisburg-Essen Laboratory, pipetting of DNA samples into Eppendorf tubes, Centre for Medical Biotechnology University Duisburg-Essenhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/laboratory-pipetting-of-dna-samples-into-eppendorf-tubes-centre-for-medical-biotechnology-university-duisburg-essen-image232210888.html Using recombinant DNA technology transgenic mouse has been engineered whose bone marrow is protected toxic effects chemotherapy Using recombinant DNA technology transgenic mouse has been engineered whose bone marrow is protected toxic effects chemotherapyhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-using-recombinant-dna-technology-transgenic-mouse-has-been-engineered-52115477.html A genomic DNA library contains the number of clones needed to encompass the entire donor genome. A genomic DNA library contains the number of clones needed to encompass the entire donor genome.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-a-genomic-dna-library-contains-the-number-of-clones-needed-to-encompass-24373134.html Laboratory, DNA samples in test tubes, Eppendorf tubes, Centre for Medical Biotechnology University Duisburg-Essen Laboratory, DNA samples in test tubes, Eppendorf tubes, Centre for Medical Biotechnology University Duisburg-Essenhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/laboratory-dna-samples-in-test-tubes-eppendorf-tubes-centre-for-medical-biotechnology-university-duisburg-essen-image232210891.html Rasburicase (recombinant urate oxidase) enzyme molecule. Used to treat and prevent tumor lysis syndrome (TLS). Cartoon model, secondary structure col Rasburicase (recombinant urate oxidase) enzyme molecule. Used to treat and prevent tumor lysis syndrome (TLS). Cartoon model, secondary structure colhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-rasburicase-recombinant-urate-oxidase-enzyme-molecule-used-to-treat-140016855.html Bacteria culture plates petri dishes with blue transformation colonies in incubator Bacteria culture plates petri dishes with blue transformation colonies in incubatorhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/bacteria-culture-plates-petri-dishes-with-blue-transformation-colonies-image6349431.html Laboratory, pipetting of DNA samples into Eppendorf tubes, Centre for Medical Biotechnology University Duisburg-Essen Laboratory, pipetting of DNA samples into Eppendorf tubes, Centre for Medical Biotechnology University Duisburg-Essenhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/laboratory-pipetting-of-dna-samples-into-eppendorf-tubes-centre-for-medical-biotechnology-university-duisburg-essen-image232210886.html Rasburicase (recombinant urate oxidase) enzyme molecule. Used to treat and prevent tumor lysis syndrome (TLS). Atoms shown as color-coded spheres. Rasburicase (recombinant urate oxidase) enzyme molecule. Used to treat and prevent tumor lysis syndrome (TLS). Atoms shown as color-coded spheres.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-rasburicase-recombinant-urate-oxidase-enzyme-molecule-used-to-treat-139954564.html Transformed bacteria colonies containing a jellyfish gene for GFP protein causing green bioluminescence. Transformed bacteria colonies containing a jellyfish gene for GFP protein causing green bioluminescence.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-transformed-bacteria-colonies-containing-a-jellyfish-gene-for-gfp-11180981.html Laboratory, DNA samples in test tubes, Eppendorf tubes, Centre for Medical Biotechnology University Duisburg-Essen Laboratory, DNA samples in test tubes, Eppendorf tubes, Centre for Medical Biotechnology University Duisburg-Essenhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/laboratory-dna-samples-in-test-tubes-eppendorf-tubes-centre-for-medical-biotechnology-university-duisburg-essen-image232210892.html Rasburicase (recombinant urate oxidase) enzyme molecule. Used to treat and prevent tumor lysis syndrome (TLS). Atoms shown as color-coded spheres. Rasburicase (recombinant urate oxidase) enzyme molecule. Used to treat and prevent tumor lysis syndrome (TLS). Atoms shown as color-coded spheres.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-rasburicase-recombinant-urate-oxidase-enzyme-molecule-used-to-treat-140016843.html Transformed bacteria colonies containing a jellyfish gene for GFP (green fluorescent protein) causing green bioluminescence. Transformed bacteria colonies containing a jellyfish gene for GFP (green fluorescent protein) causing green bioluminescence.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-transformed-bacteria-colonies-containing-a-jellyfish-gene-for-gfp-29078641.html Laboratory, DNA samples in test tubes, Eppendorf tubes, Centre for Medical Biotechnology University Duisburg-Essen Laboratory, DNA samples in test tubes, Eppendorf tubes, Centre for Medical Biotechnology University Duisburg-Essenhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/laboratory-dna-samples-in-test-tubes-eppendorf-tubes-centre-for-medical-biotechnology-university-duisburg-essen-image232210889.html Interleukin 4 (IL-4, human, recombinant) protein. Cytokine that induces differentiation of naive helper T cells to Th2 lymphocytes. 3D rendering. Interleukin 4 (IL-4, human, recombinant) protein. Cytokine that induces differentiation of naive helper T cells to Th2 lymphocytes. 3D rendering.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-4-il-4-human-recombinant-protein-cytokine-that-induces-141180762.html Biotechnology laboratory, laminar flow, a scientist is pipetting a cell culture medium into a petri dish, Centre for Medical Biotechnology laboratory, laminar flow, a scientist is pipetting a cell culture medium into a petri dish, Centre for Medicalhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/biotechnology-laboratory-laminar-flow-a-scientist-is-pipetting-a-cell-culture-medium-into-a-petri-dish-centre-for-medical-image232210912.html Transformed bacteria colonies containing a jellyfish gene for GFP (green fluorescent protein) causing green bioluminescence. Transformed bacteria colonies containing a jellyfish gene for GFP (green fluorescent protein) causing green bioluminescence.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-transformed-bacteria-colonies-containing-a-jellyfish-gene-for-gfp-59736555.html Interleukin 4 (IL-4, human, recombinant) protein. Cytokine that induces differentiation of naive helper T cells to Th2 lymphocytes. 3D rendering. Interleukin 4 (IL-4, human, recombinant) protein. Cytokine that induces differentiation of naive helper T cells to Th2 lymphocytes. 3D rendering.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-4-il-4-human-recombinant-protein-cytokine-that-induces-141180745.html Biotechnology laboratory, laminar flow, a scientist is pipetting a cell culture medium into a petri dish, Centre for Medical Biotechnology laboratory, laminar flow, a scientist is pipetting a cell culture medium into a petri dish, Centre for Medicalhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/biotechnology-laboratory-laminar-flow-a-scientist-is-pipetting-a-cell-culture-medium-into-a-petri-dish-centre-for-medical-image232210815.html Asian person student swabbing her cheek to obtain cells for DNA fingerprinting study Asian person student swabbing her cheek to obtain cells for DNA fingerprinting studyhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-asian-person-student-swabbing-her-cheek-to-obtain-cells-for-dna-fingerprinting-11180978.html Interleukin 4 (IL-4, human, recombinant) protein. Cytokine that induces differentiation of naive helper T cells to Th2 lymphocytes. 3D rendering. Interleukin 4 (IL-4, human, recombinant) protein. Cytokine that induces differentiation of naive helper T cells to Th2 lymphocytes. 3D rendering.https://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-interleukin-4-il-4-human-recombinant-protein-cytokine-that-induces-141180738.html NMR nuclear magnetic resonance spectroscope for the detection of protein structures on an atomic level, control and evaluation NMR nuclear magnetic resonance spectroscope for the detection of protein structures on an atomic level, control and evaluationhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/nmr-nuclear-magnetic-resonance-spectroscope-for-the-detection-of-protein-structures-on-an-atomic-level-control-and-evaluation-image232210904.html Rasburicase (recombinant urate oxidase) enzyme molecule. Used to treat and prevent tumor lysis syndrome (TLS). Cartoon model; N-to-C gradient coloring Rasburicase (recombinant urate oxidase) enzyme molecule. Used to treat and prevent tumor lysis syndrome (TLS). Cartoon model; N-to-C gradient coloringhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-rasburicase-recombinant-urate-oxidase-enzyme-molecule-used-to-treat-139954563.html Asian person student swabbing her cheek to obtain cells for DNA fingerprinting study Asian person student swabbing her cheek to obtain cells for DNA fingerprinting studyhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-asian-person-student-swabbing-her-cheek-to-obtain-cells-for-dna-fingerprinting-85131767.html Biotechnology laboratory, laminar flow, a scientist is pipetting a cell culture medium into a petri dish, Centre for Medical Biotechnology laboratory, laminar flow, a scientist is pipetting a cell culture medium into a petri dish, Centre for Medicalhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/biotechnology-laboratory-laminar-flow-a-scientist-is-pipetting-a-cell-culture-medium-into-a-petri-dish-centre-for-medical-image232210820.html Rasburicase (recombinant urate oxidase) enzyme molecule. Used to treat and prevent tumor lysis syndrome (TLS). Cartoon model, N-to-C gradient colorin Rasburicase (recombinant urate oxidase) enzyme molecule. Used to treat and prevent tumor lysis syndrome (TLS). Cartoon model, N-to-C gradient colorinhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-rasburicase-recombinant-urate-oxidase-enzyme-molecule-used-to-treat-139954554.html Researcher's hand loading a DNA sample into a microcentrifuge Researcher's hand loading a DNA sample into a microcentrifugehttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/stock-photo-researchers-hand-loading-a-dna-sample-into-a-microcentrifuge-11180979.html Biotechnology, fluorescence microscope, a special version of a light microscope that can visualise fluorescent labelled Biotechnology, fluorescence microscope, a special version of a light microscope that can visualise fluorescent labelledhttps://www.alamy.com/licenses-and-pricing/?v=1https://www.alamy.com/biotechnology-fluorescence-microscope-a-special-version-of-a-light-microscope-that-can-visualise-fluorescent-labelled-image232210829.html Next page Recent searches: Search Results for Recombinant Stock Photos and Images  (827) Page 1 of 9 123456789